PL3810587T3 - Podstawione alkoksypirydynyloindolosulfonoamidy - Google Patents

Podstawione alkoksypirydynyloindolosulfonoamidy

Info

Publication number
PL3810587T3
PL3810587T3 PL19731283.8T PL19731283T PL3810587T3 PL 3810587 T3 PL3810587 T3 PL 3810587T3 PL 19731283 T PL19731283 T PL 19731283T PL 3810587 T3 PL3810587 T3 PL 3810587T3
Authority
PL
Poland
Prior art keywords
indolsulfonamides
alkoxypyridinyl
substituted
substituted alkoxypyridinyl
alkoxypyridinyl indolsulfonamides
Prior art date
Application number
PL19731283.8T
Other languages
English (en)
Inventor
Cécile PEGURIER
Laurent Provins
Emre M. ISIN
Marie LEDECQ
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Publication of PL3810587T3 publication Critical patent/PL3810587T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL19731283.8T 2018-06-20 2019-06-19 Podstawione alkoksypirydynyloindolosulfonoamidy PL3810587T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18178773.0A EP3584244A1 (en) 2018-06-20 2018-06-20 Substituted alkoxypyridinyl indolsulfonamides
PCT/EP2019/066148 WO2019243398A1 (en) 2018-06-20 2019-06-19 Substituted alkoxypyridinyl indolsulfonamides

Publications (1)

Publication Number Publication Date
PL3810587T3 true PL3810587T3 (pl) 2023-02-06

Family

ID=62715911

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19731283.8T PL3810587T3 (pl) 2018-06-20 2019-06-19 Podstawione alkoksypirydynyloindolosulfonoamidy

Country Status (14)

Country Link
US (1) US11976056B2 (pl)
EP (3) EP3584244A1 (pl)
JP (1) JP7371031B2 (pl)
CN (1) CN112292375B (pl)
CA (1) CA3101086A1 (pl)
DK (1) DK3810587T3 (pl)
ES (1) ES2929829T3 (pl)
HR (1) HRP20221289T1 (pl)
HU (1) HUE060181T2 (pl)
LT (1) LT3810587T (pl)
MX (1) MX2020012823A (pl)
PL (1) PL3810587T3 (pl)
PT (1) PT3810587T (pl)
WO (1) WO2019243398A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3983384B1 (en) * 2019-06-17 2023-10-11 UCB Pharma GmbH N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treating cns disorders such as multiple sclerosis
JP2023531358A (ja) * 2020-05-01 2023-07-24 ザ チルドレンズ メディカル センター コーポレーション ミエリン形成を促進する組成物および方法
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
SI4298092T1 (sl) * 2021-02-26 2026-04-30 F. Hoffmann-La Roche Ag Novi derivati pirimidin-2-il sulfonamida
EP4311828A1 (en) * 2022-07-26 2024-01-31 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
WO2023241960A1 (en) * 2022-06-15 2023-12-21 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
CN119546608A (zh) 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖咪唑并吡啶和吡唑并吡啶磺酰胺衍生物
WO2024017863A1 (en) * 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel pyrimidinyl and triazinyl sulfonamide derivatives
WO2024017856A1 (en) 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel isoquinolinone, pyrrolopyridinone and thienopyridinone sulfonamide derivatives
CN119546572A (zh) * 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的萘基和异喹啉磺酰胺衍生物
US20260028335A1 (en) * 2022-07-20 2026-01-29 Hoffmann-La Roche Inc. Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds
MA71600A (fr) * 2022-07-28 2025-05-30 F. Hoffmann-La Roche Ag Nouveaux dérivés d'indole sulfonamide substitués en position 7
WO2024023129A1 (en) * 2022-07-28 2024-02-01 F. Hoffmann-La Roche Ag Novel 7-substituted indole sulfonamide derivatives
IL318162A (en) * 2022-08-26 2025-03-01 Hoffmann La Roche PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES ARE DISTRIBUTED
JP2025539466A (ja) * 2022-12-02 2025-12-05 リワインド セラピューティクス エン ヴェー 縮合ピロリルスルホンアミド化合物
WO2024153233A1 (en) * 2023-01-19 2024-07-25 Nanjing Immunophage Biotech Co., Ltd Compounds and their uses as gpr17 antagonists
GB2700773A (en) * 2024-05-23 2026-03-11 Pheno Therapeutics Ltd Compounds
WO2025243044A1 (en) 2024-05-23 2025-11-27 Pheno Therapeutics Limited Compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
SE9904750D0 (sv) 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
US7833722B2 (en) 2004-04-27 2010-11-16 Takeda Pharmaceutical Company Limited Ligands for G protein-coupled receptor protein and use thereof
ITMI20042007A1 (it) 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
EP1962837A4 (en) 2005-12-20 2011-12-14 Teikoku Pharma Usa Inc METHODS OF PERCUTANEOUS DELIVERY OF INDOLIC SEROTONIN RECEPTOR AGONIST AND PERCUTANEOUS COMPOSITIONS FOR USE THEREIN
EP2162183B1 (de) 2007-06-25 2019-06-26 AMW GmbH Elektrophoretisches transdermales applikationssystem
AU2009313315A1 (en) * 2008-11-07 2011-06-30 The Cleveland Clinic Foundation Compounds and methods of promoting oligodendrocyte precursor differentiation
US20110220151A1 (en) 2010-03-11 2011-09-15 Swinford Jerry L Method and Apparatus for Washing Downhole Tubulars and Equipment
EP2567698B1 (en) * 2011-09-07 2014-02-12 Rheinische Friedrich-Wilhelms-Universität Bonn GPR 17 agonists and screening assay
US9879030B2 (en) 2012-05-09 2018-01-30 Universita′ Degli Studi Di Milano GPR17 receptor modulators
EP3515426A1 (en) * 2016-09-24 2019-07-31 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
TWI754702B (zh) * 2016-12-28 2022-02-11 德商Ucb製藥有限公司 (氮雜)吲哚-和苯並呋喃-3-磺醯胺類

Also Published As

Publication number Publication date
US11976056B2 (en) 2024-05-07
US20210214337A1 (en) 2021-07-15
EP4086248A1 (en) 2022-11-09
EP3584244A1 (en) 2019-12-25
CA3101086A1 (en) 2019-12-26
EP3810587A1 (en) 2021-04-28
JP2021527696A (ja) 2021-10-14
WO2019243398A1 (en) 2019-12-26
LT3810587T (lt) 2022-11-25
JP7371031B2 (ja) 2023-10-30
HRP20221289T1 (hr) 2022-12-23
CN112292375B (zh) 2023-12-05
DK3810587T3 (da) 2022-10-31
EP3810587B1 (en) 2022-08-10
CN112292375A (zh) 2021-01-29
ES2929829T3 (es) 2022-12-01
HUE060181T2 (hu) 2023-02-28
MX2020012823A (es) 2021-02-15
PT3810587T (pt) 2022-11-14

Similar Documents

Publication Publication Date Title
DK3793565T3 (en) Mcl-1-inhibitorer
DK3467457T3 (en) Vibrationssensor
DK3759096T3 (en) Cd73-inhibitorer
CA185383S (en) Casque
CA185384S (en) Casque
CA185382S (en) Casque
CA185385S (en) Casque
LT3810587T (lt) Pakeisti alkoksipiridinilo indolsulfonamidai
DK3872428T3 (en) Indvendigt luftstyringssystem
DK3773537T3 (en) Stat3-hæmmere
DK3554057T3 (en) Audioheadsetsystem
DK3768830T3 (en) Cancerterapi
CA184993S (en) Uroflowmeter
DK3613739T3 (en) Integrin-antagonister
DK3633783T3 (en) Universal-powerbank
DK3753395T3 (en) Indvendigt luftstyringssystem
CA184991S (en) Uroflowmeter
EP3841303C0 (de) Mikrogebläse
DK3801538T3 (en) Tlr7-agonister
DK3578923T3 (en) Navigationssystem
GB201801914D0 (en) Mouth-guard
DK3768906T3 (en) Træmodul
DK3650069T3 (en) Trakeostomiventil
DK3674425T3 (en) Stålwire
DK3570498T3 (en) Adaptivt hvac-styresystem